These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 28698529)
1. Naturally Occurring Compounds: New Potential Weapons against Oxidative Stress in Chronic Kidney Disease. Signorini L; Granata S; Lupo A; Zaza G Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28698529 [TBL] [Abstract][Full Text] [Related]
2. Systemic Redox Imbalance in Chronic Kidney Disease: A Systematic Review. Poulianiti KP; Kaltsatou A; Mitrou GI; Jamurtas AZ; Koutedakis Y; Maridaki M; Stefanidis I; Sakkas GK; Karatzaferi C Oxid Med Cell Longev; 2016; 2016():8598253. PubMed ID: 27563376 [TBL] [Abstract][Full Text] [Related]
3. Reactive Oxygen Species and Their Involvement in Red Blood Cell Damage in Chronic Kidney Disease. Gwozdzinski K; Pieniazek A; Gwozdzinski L Oxid Med Cell Longev; 2021; 2021():6639199. PubMed ID: 33708334 [TBL] [Abstract][Full Text] [Related]
4. Oxidative Stress and Kidney Function: A Brief Update. Coppolino G; Leonardi G; Andreucci M; Bolignano D Curr Pharm Des; 2018; 24(40):4794-4799. PubMed ID: 30648504 [TBL] [Abstract][Full Text] [Related]
5. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Valko M; Rhodes CJ; Moncol J; Izakovic M; Mazur M Chem Biol Interact; 2006 Mar; 160(1):1-40. PubMed ID: 16430879 [TBL] [Abstract][Full Text] [Related]
6. Chronic kidney disease influences multiple systems: describing the relationship between oxidative stress, inflammation, kidney damage, and concomitant disease. Tucker PS; Scanlan AT; Dalbo VJ Oxid Med Cell Longev; 2015; 2015():806358. PubMed ID: 25861414 [TBL] [Abstract][Full Text] [Related]
7. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810 [TBL] [Abstract][Full Text] [Related]
8. Antioxidants and vascular health. Bielli A; Scioli MG; Mazzaglia D; Doldo E; Orlandi A Life Sci; 2015 Dec; 143():209-16. PubMed ID: 26585821 [TBL] [Abstract][Full Text] [Related]
9. Oxidative stress and antioxidative enzyme activities in chronic kidney disease and different types of renal replacement therapy. Stępniewska J; Gołembiewska E; Dołęgowska B; Domański M; Ciechanowski K Curr Protein Pept Sci; 2015; 16(3):243-8. PubMed ID: 25707472 [TBL] [Abstract][Full Text] [Related]
10. Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease. Granata S; Dalla Gassa A; Bellin G; Lupo A; Zaza G Biomed Res Int; 2016; 2016():9290857. PubMed ID: 27419142 [TBL] [Abstract][Full Text] [Related]
11. N-acetylcysteine as a potential strategy to attenuate the oxidative stress induced by uremic serum in the vascular system. Rodrigues SD; França KC; Dallin FT; Fujihara CK; Nascimento AJ; Pecoits-Filho R; Nakao LS Life Sci; 2015 Jan; 121():110-6. PubMed ID: 25500303 [TBL] [Abstract][Full Text] [Related]
12. Indoxyl sulfate and p-cresyl sulfate in chronic kidney disease. Could these toxins modulate the antioxidant Nrf2-Keap1 pathway? Stockler-Pinto MB; Fouque D; Soulage CO; Croze M; Mafra D J Ren Nutr; 2014 Sep; 24(5):286-91. PubMed ID: 24480117 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological models and approaches for pathophysiological conditions associated with hypoxia and oxidative stress. Farías JG; Herrera EA; Carrasco-Pozo C; Sotomayor-Zárate R; Cruz G; Morales P; Castillo RL Pharmacol Ther; 2016 Feb; 158():1-23. PubMed ID: 26617218 [TBL] [Abstract][Full Text] [Related]
14. A review of the impact of oxidative stress and some antioxidant therapies on renal damage. Tamay-Cach F; Quintana-Pérez JC; Trujillo-Ferrara JG; Cuevas-Hernández RI; Del Valle-Mondragón L; García-Trejo EM; Arellano-Mendoza MG Ren Fail; 2016; 38(2):171-5. PubMed ID: 26643776 [TBL] [Abstract][Full Text] [Related]
15. Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease. Granata S; Zaza G; Simone S; Villani G; Latorre D; Pontrelli P; Carella M; Schena FP; Grandaliano G; Pertosa G BMC Genomics; 2009 Aug; 10():388. PubMed ID: 19698090 [TBL] [Abstract][Full Text] [Related]
16. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Touyz RM Hypertension; 2004 Sep; 44(3):248-52. PubMed ID: 15262903 [TBL] [Abstract][Full Text] [Related]
18. Reactive Oxygen Species and the Aging Eye: Specific Role of Metabolically Active Mitochondria in Maintaining Lens Function and in the Initiation of the Oxidation-Induced Maturity Onset Cataract--A Novel Platform of Mitochondria-Targeted Antioxidants With Broad Therapeutic Potential for Redox Regulation and Detoxification of Oxidants in Eye Diseases. Babizhayev MA; Yegorov YE Am J Ther; 2016; 23(1):e98-117. PubMed ID: 21048433 [TBL] [Abstract][Full Text] [Related]